GlassScriptPhysician profile
Daniel M Anderson
NPI 1598925588
$5,974.74
in general payments reported to CMS, 2019-2025
22 companies · $1,593 in 2025
The $1,593 reported for 2025 was more than what 86% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $181 · 2020: $173 · 2021: $437 · 2022: $501 · 2023: $1,245 · 2024: $1,846 · 2025: $1,593.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,571 · Entertainment: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,571.45 |
| Entertainment | $111.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,431.97 | 2022-2025 | Durysta, Alphagan P, Lumigan |
| Alcon Vision LLC | $1,101.14 | 2019-2025 | Clareon, Clareon Panoptix Pro, Rocklatan |
| Johnson & Johnson Surgical Vision, INC. | $558.64 | 2021-2025 | Tecnis Iol, Veritas Vision System, Tecnis Simplicity |
| Glaukos Corporation | $524.80 | 2019-2025 | Idose, Idosetr, Istent Trabecular Micro-Bypass System Model Is3 |
| Biotissue Holdings INC. | $465.71 | 2023-2025 | |
| Bausch & Lomb Americas INC. | $355.59 | 2023-2025 | Envista Mx60 Iol, Ic-8 Apthera Iol, Xiidra |
| Sun Pharmaceutical Industries INC. | $339.06 | 2023-2025 | Cequa |
| Rxsight INC | $200.78 | 2023-2024 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Novartis Pharmaceuticals Corporation | $168.04 | 2021-2023 | |
| Oyster Point Pharma, INC. | $162.37 | 2022-2025 | Tyrvaya |
| Dompe US, INC. | $143.40 | 2022-2025 | Oxervate |
| Optos, INC. | $111.99 | 2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Allergan, INC. | $92.75 | 2020-2022 | |
| Carl Zeiss Meditec, INC. | $58.44 | 2021 | |
| Thea Pharma INC. | $55.30 | 2023-2025 | Iyuzeh |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $52.09 | 2021 | |
| Johnson & Johnson Vision Care, INC. | $40.51 | 2023 | Acuvue |
| Harrow Eye, LLC | $38.87 | 2024 | Vevye |
| Tarsus Pharmaceuticals, INC. | $23.68 | 2024 | Xdemvy |
| Astellas Pharma US INC | $18.88 | 2024 | Izervay |
| Sight Sciences, INC. | $18.73 | 2023 | Omni Surgical System, Sion Surgical Instrument |
| Mallinckrodt Hospital Products INC. | $12.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.